Booth: Country/Region: China Mainland
Technical pioneer of fine chemical and bulk drug intermediates
BroadPharma is a key hi-tech enterprise which is famous for its high technology, high growth and high efficiency. Guided by its technology, BroadPharma is specialized on developing and producing bulk drugs and pharmaceutical intermediates and providing contract -customized service.
Supported by its parent company's overseas technological advantage, rich experience and powerful abilities in the field of medicine research and development, BroadPharma has rapidly formed its own features in bulk drugs and intermediates, and established its trademark and status in this field. It has the abilities to offer clients products from gram-degree to ton-degree, our company has established a wide range of cooperative relations with twenty companies at home and abroad.
BroadPharma is a hi-tech enterprise specialized on the development, production of bulk drugs and pharmaceutical intermediates and the contract-manufacturing services. It is an also high-tech enterprise strongly supported by local government.
The parent company has set up an integrative R&D center in Beijing. It provides BroadPharma with advanced technological processes and quality control system by fully making use of overseas and domestic technologies. With ISO standard quality
control in manufacturing base, we provide pilot-scale, scale-up and bulk manufacturing from gram-degree to ton-degree.
According to the clients' requirements, our company can offer services from synthetic route design, to synthesis, purity and structural identification in strict accordance with terms on confidential agreement. We can offer clients target compound in the shortest time, from small scale test to the research, development
Making full use of the latest medical technology and market information advantages of its parent company, combining its own technique optimizations and industrialized advantages, Broadpharma is mainly engaged in the technical development and production of featured bulk drugs and pharmaceutical intermediates. Currently, our company has several advanced technique platforms of international scale in bulk drug synthesis and technologies.
To become a supplier of leading pharmaceutical technologies and bulk drug intermediates with world class technologies and popular price.
Internationalized and Specialized Team:
Beijing Research and Development Center has gathered more than 20 experts on organic synthesis and medical chemistry. Meanwhile, our company has established a wide range of network with Organic Institute of Chinese Academy of Sciences,
Nankai University, Lanzhou University etc. And established joint labs with some of universities, which have ensured BroadPharma' leading position in technology.
The Company's technical centers are in charged by key technical team numbers, which graduated from Beijing University, China Academy of Sciences and Nankai University etc. They have been engaged in the research and development, manufacturing of organic synthesis and medical chemistry for years.
Parent company has also invited many famous foreign scientists, scholars and domestically famous experts in the fields of organic synthesis and medical chemistry as our company's technical and management advisers. In addition, we have set up Technology and Management Advisory Committee.
Core Competitive Power:
Advanced manufacturing facilities, all-around productive capacity:
Our company possesses complete manufacturing facilities for pilot scale and scale-up experiment, and two industrialized scale-up manufacturing bases. Our company's manufacturing base has scale-up workshops, production workshops, quality inspection center and unusual equipment including deep freezing （－80℃）, high temperature, high-pressure hydrogenation etc..
Complete world class quality assurance system：
Our company has set up strict management system and complete quality assurance systems. Many products are produced in accordance with international quality certification system (ISO9001). Complete quality assurance system has used pharmacopoeia of European and American countries for reference. In addition, we
have successfully helped our cooperative partners with DMF registration for many products in FDA, EU, Australia and Canada.
Our company pays much attention to the stability of experiments, verification of analysis method and the investigation of OOS to ensure the accuracy and scientificness of analytical data in order to provide best service to our clients. So what BroadPharma's cooperative partners may obtain bulk drugs and intermediates with advanced technology, lowest price and stable products.
Driving Development, Wide Range of Cooperation：
Guided by market, our company has developed more than ten kinds of processes with domestically lowest cost. Many hi-tech products are being or to be produced in large quantities. Meanwhile, BroadPharma has established solid trading and technical cooperative relationships with more than twenty pharmaceutical enterprises at home and abroad. Many intermediates are exported to Europe, America and other Asian countries.
Cooperation and Exchange：
Welcome to contact our company for business cooperation and negotiation. We sincerely hope that we will have the opportunities to serve you.